|
(b)(4).To date the device has not been returned.If the device or further details are received at the later date a supplemental medwatch will be sent.Attempts are being made to receive additional information.To date no response has been provided.If further details are received at a later date a supplemental medwatch will be sent.Questions for patient #1: the patient demographic info: age, gender, weight, bmi at the time of index procedure? date of index left tha procedure? on what tissues were vicryl sutures (j261h and j945h) used? product lot numbers for j261h and j945h? what was the tissue condition, i.E., normal or thin, calcified, fragile, diseased? were there any pre-existing signs/symptoms of active inflammation/infection prior to this surgical procedure? did the patient receive prophylactic antibiotics pre-, intra- or post operation? please specify.Were any pre-op cleansing procedures or products changed recently? if yes, please describe.Did the operating surgeon observe any suture deficiency or anomaly before, during or after the suture placement? please specify.Please explain/clarify what does it mean by ¿eruptions (5- and 8-months post op)¿? how were both ¿eruptions¿ resolved? were oral antibiotics used both times at 5- and 8-months post op? please specify.Other relevant patient factors/comorbidities/concomitant medications? what is physician¿s opinion as to the etiology of or contributing factors to this event? what is the patient¿s current status?.
|
|
It was reported that the patient underwent an elective left tha procedure on unknown date and the suture was used.The patient experienced post-op inflammation at the suture site.The patient presented with pain, erythema and swelling along the suture line 8 months post op.The patient was placed on oral antibiotics when inflammatory markers were found to be elevated, esr and crp.It was also reported that the patient had two such eruptions, 5 and 8 months post op, and both have resolved.Additional information has been requested.
|